title: Dissociation between perceptual processing and priming in long-term lorazepam users.
abstract: Acute effects of lorazepam on visual information processing, perceptual priming and explicit memory are well established. However, visual processing and perceptual priming have rarely been explored in long-term lorazepam users. By exploring these functions it was possible to test the hypothesis that difficulty in processing visual information may lead to deficiencies in perceptual priming. Using a simple blind procedure, we tested explicit memory, perceptual priming and visual perception in 15 long-term lorazepam users and 15 control subjects individually matched according to sex, age and education level. Explicit memory, perceptual priming, and the identification of fragmented pictures were found to be preserved in long-term lorazepam users, contrary to what is usually observed after an acute drug intake. The processing of visual contour, on the other hand, was still significantly impaired. These results suggest that the effects observed on low-level visual perception are independent of the acute deleterious effects of lorazepam on perceptual priming. A comparison of perceptual priming in subjects with low- vs. high-level identification of new fragmented pictures further suggests that the ability to identify fragmented pictures has no influence on priming. Despite the fact that they were treated with relatively low doses and far from peak plasma concentration, it is noteworthy that in long-term users memory was preserved.
authors.affiliation: INSERM U666, Department of Psychiatry, Hôpitaux Universitaires de Strasbourg, Strasbourg, France. giersch@alsace.u-strasbg.fr
authors.forename: Anne
authors.initials: A
authors.lastname: Giersch
authors.forename: Pierre
authors.initials: P
authors.lastname: Vidailhet
mesh_terms: D000328:Adult; D000368:Aged; D014151:Anti-Anxiety Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy / Q000523:psychology; D003463:Cues; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects; D008140:Lorazepam / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008568:Memory / Q000187:drug effects; D011939:Mental Recall / Q000187:drug effects; D008875:Middle Aged; D010775:Photic Stimulation; D011569:Psychiatric Status Rating Scales; D011680:Pupil / Q000187:drug effects; D014796:Visual Perception / Q000187:drug effects*; D014888:Wechsler Scales
chemical_list: D014151:Anti-Anxiety Agents; D006993:Hypnotics and Sedatives; D008140:Lorazepam